LYCOS RETRIEVER
Kemetic
RECENTLY UPDATED TOPICS UNDER KEMETIC
|
ISIS
Isis is exploiting its expertise in RNA to discover and develop novel drugs for its product pipeline and for its partners. The Company has successfully commercialized the world's first antisense drug and has 18 drugs in development. Isis' drug development programs are focused on treating cardiovascular and metabolic diseases. Isis' partners are developing antisense drugs invented by Isis to treat a wide variety of diseases. Ibis Biosciences, Inc., Isis' wholly owned subsidiary, is developing and commercializing the Ibis T5000(TM) Biosensor System, a revolutionary system to identify infectious organisms. Isis is a joint owner of Regulus Therapeutics LLC, a joint venture focused on the discovery, development and commercialization of microRNA therapeutics.
Source: nasdaq.com (built 14585 days ago)
|
|
TOPICS IN KEMETIC
|
||
KEMETIC CATEGORIES
There are currently no sub-categories under Kemetic